Base de dados : HANSEN
Pesquisa : RIFAMPINA/TU [Descritor de assunto]
Referências encontradas : 2 [refinar]
Mostrando: 1 .. 2   no formato [Detalhado]

página 1 de 1

  1 / 2 HANSEN  
              next record last record
seleciona
para imprimir
Id:22742
Autor:Stefani, Mariane M. A; Martelli, Celina M. T; Gillis, Thomas P; Krahenbuhl, James L
Título:In situ type 1 cytokine gene expression and mechanism associated with early leprosy progression
..-
Fonte:s.l; s.n; 2003. 8 p. ilus.
Resumo:We explored the prognostic value of in situ cytokine patterns in 39 patients with single-skin-lesion paucibacillary leprosy before single-dose therapy, with 3 years of follow-up. Interferon (IFN)-gamma, interleukin (IL)-12, IL-10, IL-4, tumor necrosis factor (TNF)-alpha, and macrophage inflammatory protein (MIP)-1alpha mRNA was quantified in skin biopsy samples at diagnosis, and Mycobacterium leprae DNA was detected in 51.4% of cases. Type 1 immunity predominance with measurable IFN-gamma and undetectable IL-4, which is indicative of effective cell-mediated immunity, is compatible with both the reversal reactions (33.3%) and the resolution of lesions (64.1%) observed. A positive correlation between IL-12 and IFN-gamma indicated type 1 polarization via IL-12. The TNF-alpha/MIP-1alpha correlation implied the TNF-alpha induction of chemokines, which is important for granuloma formation. Positive correlations between key regulatory cytokines-IL-10 and IFN-gamma, IL-10 and IL-12, and IL-10 and TNF-alpha-suggests that there may be some level of an intralesional pro- or anti-inflammatory mechanism essential in avoiding immunopathology. (AU).
Descritores:Anticorpos Antibacterianos/BL
Biópsia
Estudos de Coortes
Citocinas/BI/*GE/IM
Regulação Bacteriana da Expressão Gênica/*IM
Hanseníase/DT/*GE/IM
Minociclina/TU
Mycobacterium leprae/*GE/IM
Ofloxacino/TU
Prognóstico
RNA Mensageiro/BI/GE
RNA Viral/BI/GE
Reação em Cadeia da Polimerase Via Transcriptase Reversa
Rifampina/TU
Limites:Adolescente
Adulto
Criança
Feminino
Humano
Masculino
Células Th1/IM
Localização:BR191.1; 01884/s


  2 / 2 HANSEN  
              first record previous record
seleciona
para imprimir
Id:10259
Autor:Feingold, David S; Wagner Junior, Richard F
Título:Antibacterial therapy
..-
Fonte:s.l; s.n; 1986. 14 p. tab.
Resumo:The current status of antibacterial therapy is reviewed, and special emphasis is placed on those agents that might be most useful in cutaneous medicine. (AU).
Descritores:ANTIINFECCIOSOS LOCAIS/TU
ANTIBIOTICOS/*TU
ANTIBIOTICOS LACTAMICOS/TU
CEFALOSPORINAS/TU
CLINDAMICINA/TU
COMBINACAO DE MEDICAMENTOS/TU
ERITROMICINA/TU
METICILINA/TU
METRONIDAZOL/TU
ACIDO NALIDIXICO/AA
RESISTENCIA A PENICILINA
PENICILINAS/TU
RIFAMPINA/TU
DERMATOPATIAS INFECCIOSAS/*DT
INFECCOES ESTAFILOCOCICAS/DT
STAPHYLOCOCCUS AUREUS/DE
SULFAMETOXAZOL/TU
TETRACICLINA/TU
TRIMETOPRIM/TU
COMBINACAO TRIMETOPRIM-SULFAMETOXAZOL
VANCOMICINA/TU
Limites:HUMANO
Localização:BR191.1; 0076/cme



página 1 de 1
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information